Galena Biopharma, Inc. investigation

February 17, 2014 by

Stocks and sharesSTOLL BERNE, an Oregon class action and securities fraud law firm, is investigating potential claims concerning whether Galena Biopharma, Inc. (“Galena”) (NASDAQ: GALE),  its board of directors or officers violated state or federal securities laws, or breached fiduciary duties owed to shareholders.

The investigation relates to the recent drop in Galena’s stock price following reports questioning Galena’s practices with respect to stock promotion.

If you purchased Galena shares and wish to discuss the matter with one of our lawyers, please contact Keith Dubanevich or Jennifer Wagner.

Categories: Breaking News


Jen Wagner
As co-managing shareholder and as a trial lawyer who practices in the areas of complex business, securities, financial fraud, employment, and class action litigation, Jen regularly represents clients in state and federal court and in private arbitrations. Jen advocates for her clients with intelligence and integrity, and is particularly adept at navigating the unique strategic and procedural challenges of complex business and class action litigation. Her clients value her approachable and cool-headed manner in litigating and resolving contentious cases.

Legal Disclaimer

The information contained in this blog does not constitute legal advice, and does not create an attorney-client relationship. We make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this blog.